{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T17:17:06Z","timestamp":1794331026197,"version":"4.9.0"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2014,10,9]],"date-time":"2014-10-09T00:00:00Z","timestamp":1412812800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"published-print":{"date-parts":[[2014,12]]},"DOI":"10.1186\/1471-2334-14-542","type":"journal-article","created":{"date-parts":[[2014,10,9]],"date-time":"2014-10-09T15:01:21Z","timestamp":1412866881000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":56,"title":["Successful MDR-TB treatment regimens including Amikacin are associated with high rates of hearing loss"],"prefix":"10.1186","volume":"14","author":[{"given":"Chawangwa","family":"Modongo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rafal S","family":"Sobota","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Boikobo","family":"Kesenogile","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ronald","family":"Ncube","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giorgio","family":"Sirugo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott M","family":"Williams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicola M","family":"Zetola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2014,10,9]]},"reference":[{"key":"4110_CR1","volume-title":"Guidelines for the Clinical and Operational Management of Drug-Resistant Tuberculosis","author":"JA Caminero","year":"2013","unstructured":"Caminero JA: Guidelines for the Clinical and Operational Management of Drug-Resistant Tuberculosis. 2013, 68 boulevard St Michel, 75006 Paris, Franc: International Union Against Tuberculosis and Lung Disease (The Union)"},{"key":"4110_CR2","volume-title":"Guidelines for the Programmatic Management of Drug-Resistant Tuberculosis: 2011 Update","author":"Organization WH","year":"2011","unstructured":"Organization WH: Guidelines for the Programmatic Management of Drug-Resistant Tuberculosis: 2011 Update. 2011, Geneva: WHO\/HTM\/TB\/2011.6"},{"key":"4110_CR3","volume-title":"Drug-Resistant Tuberculosis: A Survival Guide for Clinicians","author":"Health FJCNTCaCDoP","year":"2008","unstructured":"Health FJCNTCaCDoP: Drug-Resistant Tuberculosis: A Survival Guide for Clinicians. 2008, 2","edition":"2"},{"key":"4110_CR4","volume-title":"Multidrug-resistant tuberculosis (MDR-TB) October 2013 Update","author":"World Health O","year":"2013","unstructured":"World Health O: Multidrug-resistant tuberculosis (MDR-TB) October 2013 Update. 2013"},{"key":"4110_CR5","volume-title":"National Tuberculosis Manual","author":"BNT Program","year":"2011","unstructured":"Program BNT: National Tuberculosis Manual. 2011, Ministry of Health: Gaborone, 7","edition":"7"},{"issue":"2","key":"4110_CR6","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1136\/jmg.34.2.169","volume":"34","author":"A Pandya","year":"1997","unstructured":"Pandya A, Xia X, Radnaabazar J, Batsuuri J, Dangaansuren B, Fischel-Ghodsian N, Nance WE: Mutation in the mitochondrial 12S rRNA gene in two families from Mongolia with matrilineal aminoglycoside ototoxicity. J Med Genet. 1997, 34 (2): 169-172. 10.1136\/jmg.34.2.169.","journal-title":"J Med Genet"},{"issue":"3","key":"4110_CR7","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1016\/S0196-0709(97)90078-8","volume":"18","author":"N Fischel-Ghodsian","year":"1997","unstructured":"Fischel-Ghodsian N, Prezant TR, Chaltraw WE, Wendt KA, Nelson RA, Arnos KS, Falk RE: Mitochondrial gene mutation is a significant predisposing factor in aminoglycoside ototoxicity. Am J Otolaryngol. 1997, 18 (3): 173-178. 10.1016\/S0196-0709(97)90078-8.","journal-title":"Am J Otolaryngol"},{"issue":"6","key":"4110_CR8","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1016\/0196-0709(95)90078-0","volume":"16","author":"N Fischel-Ghodsian","year":"1995","unstructured":"Fischel-Ghodsian N, Prezant TR, Fournier P, Stewart IA, Maw M: Mitochondrial mutation associated with nonsyndromic deafness. Am J Otolaryngol. 1995, 16 (6): 403-408. 10.1016\/0196-0709(95)90078-0.","journal-title":"Am J Otolaryngol"},{"issue":"6","key":"4110_CR9","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1016\/0196-0709(93)90113-L","volume":"14","author":"N Fischel-Ghodsian","year":"1993","unstructured":"Fischel-Ghodsian N, Prezant TR, Bu X, Oztas S: Mitochondrial ribosomal RNA gene mutation in a patient with sporadic aminoglycoside ototoxicity. Am J Otolaryngol. 1993, 14 (6): 399-403. 10.1016\/0196-0709(93)90113-L.","journal-title":"Am J Otolaryngol"},{"issue":"20","key":"4110_CR10","doi-asserted-by":"publisher","first-page":"1106","DOI":"10.1056\/NEJM198005153022002","volume":"302","author":"CR Smith","year":"1980","unstructured":"Smith CR, Lipsky JJ, Laskin OL, Hellmann DB, Mellits ED, Longstreth J, Lietman PS: Double-blind comparison of the nephrotoxicity and auditory toxicity of gentamicin and tobramycin. N Engl J Med. 1980, 302 (20): 1106-1109. 10.1056\/NEJM198005153022002.","journal-title":"N Engl J Med"},{"issue":"6","key":"4110_CR11","doi-asserted-by":"publisher","first-page":"780","DOI":"10.1128\/AAC.15.6.780","volume":"15","author":"CR Smith","year":"1979","unstructured":"Smith CR, Lipsky JJ, Lietman PS: Relationship between aminoglycoside-induced nephrotoxicity and auditory toxicity. Antimicrob Agents Chemother. 1979, 15 (6): 780-782. 10.1128\/AAC.15.6.780.","journal-title":"Antimicrob Agents Chemother"},{"issue":"3","key":"4110_CR12","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1093\/infdis\/149.3.443","volume":"149","author":"RD Moore","year":"1984","unstructured":"Moore RD, Smith CR, Lietman PS: The association of aminoglycoside plasma levels with mortality in patients with gram-negative bacteremia. J Infect Dis. 1984, 149 (3): 443-448. 10.1093\/infdis\/149.3.443.","journal-title":"J Infect Dis"},{"issue":"3","key":"4110_CR13","doi-asserted-by":"publisher","first-page":"352","DOI":"10.7326\/0003-4819-100-3-352","volume":"100","author":"RD Moore","year":"1984","unstructured":"Moore RD, Smith CR, Lipsky JJ, Mellits ED, Lietman PS: Risk factors for nephrotoxicity in patients treated with aminoglycosides. Ann Intern Med. 1984, 100 (3): 352-357. 10.7326\/0003-4819-100-3-352.","journal-title":"Ann Intern Med"},{"issue":"11","key":"4110_CR14","doi-asserted-by":"publisher","first-page":"1538","DOI":"10.1086\/420742","volume":"38","author":"CA Peloquin","year":"2004","unstructured":"Peloquin CA, Berning SE, Nitta AT, Simone PM, Goble M, Huitt GA, Iseman MD, Cook JL, Curran-Everett D: Aminoglycoside toxicity: daily versus thrice-weekly dosing for treatment of mycobacterial diseases. Clin Infect Dis. 2004, 38 (11): 1538-1544. 10.1086\/420742.","journal-title":"Clin Infect Dis"},{"issue":"5","key":"4110_CR15","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1016\/S0030-6665(20)30762-3","volume":"26","author":"GJ Matz","year":"1993","unstructured":"Matz GJ: Aminoglycoside cochlear ototoxicity. Otolaryngol Clin North Am. 1993, 26 (5): 705-712.","journal-title":"Otolaryngol Clin North Am"},{"issue":"6","key":"4110_CR16","first-page":"397","volume":"3","author":"SA Fausti","year":"1992","unstructured":"Fausti SA, Frey RH, Henry JA, Olson DJ, Schaffer HI: Early detection of ototoxicity using high-frequency, tone-burst-evoked auditory brainstem responses. J Am Acad Audiol. 1992, 3 (6): 397-404.","journal-title":"J Am Acad Audiol"},{"issue":"6","key":"4110_CR17","doi-asserted-by":"publisher","first-page":"1026","DOI":"10.1093\/infdis\/165.6.1026","volume":"165","author":"SA Fausti","year":"1992","unstructured":"Fausti SA, Henry JA, Schaffer HI, Olson DJ, Frey RH, McDonald WJ: High-frequency audiometric monitoring for early detection of aminoglycoside ototoxicity. J Infect Dis. 1992, 165 (6): 1026-1032. 10.1093\/infdis\/165.6.1026.","journal-title":"J Infect Dis"},{"issue":"5","key":"4110_CR18","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1097\/MOO.0b013e3282ef772d","volume":"15","author":"MD Rizzi","year":"2007","unstructured":"Rizzi MD, Hirose K: Aminoglycoside ototoxicity. Curr Opin Otolaryngol Head Neck Surg. 2007, 15 (5): 352-357. 10.1097\/MOO.0b013e3282ef772d.","journal-title":"Curr Opin Otolaryngol Head Neck Surg"},{"issue":"1","key":"4110_CR19","doi-asserted-by":"publisher","first-page":"119","DOI":"10.2174\/138161207779313731","volume":"13","author":"E Selimoglu","year":"2007","unstructured":"Selimoglu E: Aminoglycoside-induced ototoxicity. Curr Pharm Des. 2007, 13 (1): 119-126. 10.2174\/138161207779313731.","journal-title":"Curr Pharm Des"},{"issue":"6","key":"4110_CR20","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1128\/AAC.33.6.797","volume":"33","author":"RE Brummett","year":"1989","unstructured":"Brummett RE, Fox KE: Aminoglycoside-induced hearing loss in humans. Antimicrob Agents Chemother. 1989, 33 (6): 797-800. 10.1128\/AAC.33.6.797.","journal-title":"Antimicrob Agents Chemother"},{"issue":"1","key":"4110_CR21","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1164\/rccm.200907-0989OC","volume":"181","author":"NR Gandhi","year":"2010","unstructured":"Gandhi NR, Shah NS, Andrews JR, Vella V, Moll AP, Scott M, Weissman D, Marra C, Lalloo UG, Friedland GH, Tugela Ferry Care and Research (TF CARES), et al: HIV coinfection in multidrug- and extensively drug-resistant tuberculosis results in high early mortality. Am J Respir Crit Care Med. 2010, 181 (1): 80-86. 10.1164\/rccm.200907-0989OC.","journal-title":"Am J Respir Crit Care Med"},{"issue":"16","key":"4110_CR22","doi-asserted-by":"publisher","first-page":"1137","DOI":"10.1056\/NEJM199304223281601","volume":"328","author":"PM Small","year":"1993","unstructured":"Small PM, Shafer RW, Hopewell PC, Singh SP, Murphy MJ, Desmond E, Sierra MF, Schoolnik GK: Exogenous reinfection with multidrug-resistant Mycobacterium tuberculosis in patients with advanced HIV infection. N Engl J Med. 1993, 328 (16): 1137-1144. 10.1056\/NEJM199304223281601.","journal-title":"N Engl J Med"},{"issue":"8","key":"4110_CR23","doi-asserted-by":"publisher","first-page":"1130","DOI":"10.5588\/ijtld.11.0824","volume":"16","author":"NM Zetola","year":"2012","unstructured":"Zetola NM, Olabiyi B, Ramogola-Masire D, Modongo C: Measuring stigma: are we looking in the right places?. Int J Tuberc Lung Dis. 2012, 16 (8): 1130-1131. 10.5588\/ijtld.11.0824.","journal-title":"Int J Tuberc Lung Dis"},{"issue":"11","key":"4110_CR24","doi-asserted-by":"publisher","first-page":"1529","DOI":"10.5588\/ijtld.12.0026","volume":"16","author":"NM Zetola","year":"2012","unstructured":"Zetola NM, Modongo C, Kip EC, Gross R, Bisson GP, Collman RG: Alcohol use and abuse among patients with multidrug-resistant tuberculosis in Botswana. Int J Tuberc Lung Dis. 2012, 16 (11): 1529-1534. 10.5588\/ijtld.12.0026.","journal-title":"Int J Tuberc Lung Dis"},{"issue":"11","key":"4110_CR25","doi-asserted-by":"publisher","first-page":"1561","DOI":"10.5588\/ijtld.12.0403","volume":"16","author":"C Modongo","year":"2012","unstructured":"Modongo C, Zetola NM: Prevalence of hypothyroidism among MDR-TB patients in Botswana. Int J Tuberc Lung Dis. 2012, 16 (11): 1561-1562. 10.5588\/ijtld.12.0403.","journal-title":"Int J Tuberc Lung Dis"},{"key":"4110_CR26","first-page":"258","volume-title":"2011 Global Tuberculosis Control","author":"Organization WH","year":"2011","unstructured":"Organization WH: 2011 Global Tuberculosis Control. 2011, 258-"},{"key":"4110_CR27","volume-title":"Final report: Botswana AIDS Impact Survey III (BAIS III - 2008)","author":"Botswana Ministry of Health, Office of Statistics","year":"2009","unstructured":"Botswana Ministry of Health, Office of Statistics: Final report: Botswana AIDS Impact Survey III (BAIS III - 2008). 2009, Gaborone, Botswana"},{"issue":"5","key":"4110_CR28","doi-asserted-by":"publisher","first-page":"2321","DOI":"10.1128\/JCM.42.5.2321-2325.2004","volume":"42","author":"M Cruciani","year":"2004","unstructured":"Cruciani M, Scarparo C, Malena M, Bosco O, Serpelloni G, Mengoli C: Meta-analysis of BACTEC MGIT 960 and BACTEC 460\u00a0TB, with or without solid media, for detection of mycobacteria. J Clin Microbiol. 2004, 42 (5): 2321-2325. 10.1128\/JCM.42.5.2321-2325.2004.","journal-title":"J Clin Microbiol"},{"issue":"10","key":"4110_CR29","doi-asserted-by":"publisher","first-page":"3753","DOI":"10.1128\/JCM.40.10.3753-3756.2002","volume":"40","author":"B Madison","year":"2002","unstructured":"Madison B, Gross W, George I, Sloutsky A, Washabaugh G, Robinson-Dunn B, Lipman H, Metchock B, Mazurek G, Ridderhof J: Multicenter evaluation of a nonweekend reading schedule for radiometric pyrazinamide susceptibility testing of Mycobacterium tuberculosis. J Clin Microbiol. 2002, 40 (10): 3753-3756. 10.1128\/JCM.40.10.3753-3756.2002.","journal-title":"J Clin Microbiol"},{"issue":"11","key":"4110_CR30","doi-asserted-by":"publisher","first-page":"3976","DOI":"10.1128\/JCM.40.11.3976-3979.2002","volume":"40","author":"B Madison","year":"2002","unstructured":"Madison B, Robinson-Dunn B, George I, Gross W, Lipman H, Metchock B, Sloutsky A, Washabaugh G, Mazurek G, Ridderhof J: Multicenter evaluation of ethambutol susceptibility testing of mycobacterium tuberculosis by agar proportion and radiometric methods. J Clin Microbiol. 2002, 40 (11): 3976-3979. 10.1128\/JCM.40.11.3976-3979.2002.","journal-title":"J Clin Microbiol"},{"key":"4110_CR31","volume-title":"2012 Botswana National HIV & AIDS Treatment Guidelines","author":"Government of Botswana MoH","year":"2012","unstructured":"Government of Botswana MoH: 2012 Botswana National HIV & AIDS Treatment Guidelines. 2012, Gaborone"},{"key":"4110_CR32","volume-title":"Definitions and reporting framework for tuberculosis\u2013 2013 revision","author":"WH Organization","year":"2013","unstructured":"Organization WH: Definitions and reporting framework for tuberculosis\u2013 2013 revision. 2013"},{"issue":"4","key":"4110_CR33","doi-asserted-by":"publisher","first-page":"774","DOI":"10.1111\/j.1532-5415.2008.01634.x","volume":"56","author":"M Nevins","year":"2008","unstructured":"Nevins M, Bright M: Cockcroft-Gault formula for diagnosing moderate kidney failure. J Am Geriatr Soc. 2008, 56 (4): 774-","journal-title":"J Am Geriatr Soc"},{"issue":"2","key":"4110_CR34","doi-asserted-by":"publisher","first-page":"89","DOI":"10.5414\/CNP66089","volume":"66","author":"A Shoker","year":"2006","unstructured":"Shoker A, Hossain MA, Koru-Sengul T, Raju DL, Cockcroft D: Performance of creatinine clearance equations on the original Cockcroft-Gault population. Clin Nephrol. 2006, 66 (2): 89-97.","journal-title":"Clin Nephrol"},{"issue":"3","key":"4110_CR35","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1681\/ASN.2004070549","volume":"16","author":"M Froissart","year":"2005","unstructured":"Froissart M, Rossert J, Jacquot C, Paillard M, Houillier P: Predictive performance of the modification of diet in renal disease and Cockcroft-Gault equations for estimating renal function. J Am Soc Nephrol. 2005, 16 (3): 763-773. 10.1681\/ASN.2004070549.","journal-title":"J Am Soc Nephrol"},{"issue":"2","key":"4110_CR36","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1681\/ASN.2004060447","volume":"16","author":"ED Poggio","year":"2005","unstructured":"Poggio ED, Wang X, Greene T, Van Lente F, Hall PM: Performance of the modification of diet in renal disease and Cockcroft-Gault equations in the estimation of GFR in health and in chronic kidney disease. J Am Soc Nephrol. 2005, 16 (2): 459-466. 10.1681\/ASN.2004060447.","journal-title":"J Am Soc Nephrol"},{"issue":"3","key":"4110_CR37","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1007\/s002849900095","volume":"33","author":"N Rastogi","year":"1996","unstructured":"Rastogi N, Labrousse V, Goh KS: In vitro activities of fourteen antimicrobial agents against drug susceptible and resistant clinical isolates of Mycobacterium tuberculosis and comparative intracellular activities against the virulent H37Rv strain in human macrophages. Curr Microbiol. 1996, 33 (3): 167-175. 10.1007\/s002849900095.","journal-title":"Curr Microbiol"},{"issue":"7","key":"4110_CR38","first-page":"622","volume":"6","author":"P de Jager","year":"2002","unstructured":"de Jager P, van Altena R: Hearing loss and nephrotoxicity in long-term aminoglycoside treatment in patients with tuberculosis. Int J Tuberc Lung Dis. 2002, 6 (7): 622-627.","journal-title":"Int J Tuberc Lung Dis"},{"issue":"6 Pt 2","key":"4110_CR39","doi-asserted-by":"crossref","first-page":"363","DOI":"10.7196\/SAMJ.4964","volume":"102","author":"T Harris","year":"2012","unstructured":"Harris T, Bardien S, Schaaf HS, Petersen L, De Jong G, Fagan JJ: Aminoglycoside-induced hearing loss in HIV-positive and HIV-negative multidrug-resistant tuberculosis patients. S Afr Med J. 2012, 102 (6 Pt 2): 363-366.","journal-title":"S Afr Med J"},{"issue":"6","key":"4110_CR40","doi-asserted-by":"publisher","first-page":"956","DOI":"10.1128\/AAC.9.6.956","volume":"9","author":"RE Black","year":"1976","unstructured":"Black RE, Lau WK, Weinstein RJ, Young LS, Hewitt WL: Ototoxicity of amikacin. Antimicrob Agents Chemother. 1976, 9 (6): 956-961. 10.1128\/AAC.9.6.956.","journal-title":"Antimicrob Agents Chemother"},{"issue":"4","key":"4110_CR41","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1128\/AAC.17.4.707","volume":"17","author":"M Barza","year":"1980","unstructured":"Barza M, Lauermann MW, Tally FP, Gorbach SL: Prospective, randomized trial of netilmicin and amikacin, with emphasis on eighth-nerve toxicity. Antimicrob Agents Chemother. 1980, 17 (4): 707-714. 10.1128\/AAC.17.4.707.","journal-title":"Antimicrob Agents Chemother"},{"issue":"3","key":"4110_CR42","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1016\/0378-4274(90)90033-I","volume":"52","author":"PJ Govaerts","year":"1990","unstructured":"Govaerts PJ, Claes J, van de Heyning PH, Jorens PG, Marquet J, De Broe ME: Aminoglycoside-induced ototoxicity. Toxicol Lett. 1990, 52 (3): 227-251. 10.1016\/0378-4274(90)90033-I.","journal-title":"Toxicol Lett"},{"issue":"1\u20132","key":"4110_CR43","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/S0378-5955(98)00190-7","volume":"128","author":"CD Mills","year":"1999","unstructured":"Mills CD, Loos BM, Henley CM: Increased susceptibility of male rats to kanamycin-induced cochleotoxicity. Hear Res. 1999, 128 (1\u20132): 75-79.","journal-title":"Hear Res"},{"issue":"1\u20132","key":"4110_CR44","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/S0378-5955(01)00303-3","volume":"158","author":"WJ Wu","year":"2001","unstructured":"Wu WJ, Sha SH, McLaren JD, Kawamoto K, Raphael Y, Schacht J: Aminoglycoside ototoxicity in adult CBA, C57BL and BALB mice and the Sprague-Dawley rat. Hear Res. 2001, 158 (1\u20132): 165-178.","journal-title":"Hear Res"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2334-14-542.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1471-2334-14-542\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2334-14-542","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2334-14-542.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,2]],"date-time":"2021-09-02T07:10:01Z","timestamp":1630566601000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/1471-2334-14-542"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,10,9]]},"references-count":44,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,12]]}},"alternative-id":["4110"],"URL":"https:\/\/doi.org\/10.1186\/1471-2334-14-542","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,10,9]]},"assertion":[{"value":"3 February 2014","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 September 2014","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 October 2014","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"542"}}